Sequent Scientific Limited
SEQUENT (NSE)

98.15

0.00
Proj. ROE (%)
8.95
Proj. P/E (x)
37.29
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
3.13
Proj. Revenue ( Cr.)
1,597.05

Stock View

BUY
Share on
The average score for Sequent Scientific Limited stands at 1 against 1, three months back.

SeQuent Scientific Limited is an India-based integrated pharmaceutical company. The Company operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The Company through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
114.85
100 DMA ()
127.67
200 DMA ()
156.47
52 Weeks Range
82.00
336.50
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity